MATN3: Potential Drug Target for Alzheimer's and Other Disorders

Target Name: MATN3

NCBI ID: G4148

MATN3

MATN3: Potential Drug Target for Alzheimer's and Other Disorders

MATN3, also known as EDM5, is a protein that is expressed in the brain and is known for its role in the development and progression of various neurological disorders, including Alzheimer's disease. The protein is a key component of the neurotransmitter system, which is responsible for transmitting electrical signals throughout the brain.

MATN3 is a transmembrane protein that is expressed in the brain and is involved in the production of the neurotransmitter serotonin. Serotonin is a well-known neurotransmitter that is involved in regulating mood, appetite, and sleep. It is also involved in the development and maintenance of neural networks, which are the fundamental units of the brain.

MATN3 is known to be involved in the development of neurodegenerative disorders, including Alzheimer's disease. Studies have shown that MATN3 is overexpressed in the brains of individuals with Alzheimer's disease and that it is involved in the destruction of neural networks in the brain. This suggests that MATN3 may be a potential drug target or biomarker for Alzheimer's disease.

In addition to its involvement in the development of Alzheimer's disease, MATN3 is also known to be involved in the treatment of other neurological disorders. For example, MATN3 has been shown to be involved in the treatment of depression and anxiety disorders. Studies have shown that MATN3 is involved in the regulation of brain activity in individuals with depression and that it may be a useful target for the treatment of this disorder.

MATN3 is also involved in the regulation of pain and inflammation. Studies have shown that MATN3 is involved in the regulation of pain perception and that it may be a potential target for the treatment of chronic pain.

In conclusion, MATN3 is a protein that is expressed in the brain and is involved in the production of serotonin and the development and progression of neurodegenerative disorders. It is also involved in the regulation of mood, appetite, and sleep, as well as pain and inflammation. As such, MATN3 may be a potential drug target or biomarker for a variety of neurological disorders, including Alzheimer's disease. Further research is needed to fully understand the role of MATN3 in the brain and its potential as a drug.

Protein Name: Matrilin 3

Functions: Major component of the extracellular matrix of cartilage and may play a role in the formation of extracellular filamentous networks

The "MATN3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MATN3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets